The FDA certainly wasn’t the biggest newsmaker this week, but it did create some buzz in the blogosphere – mostly due to the Prescription Drug User Fee Act, or PDUFA, which is up for Congressional reauthorization. Matt Madia at Reg Watch and Merrill Goozner at GoozNews are tracking PDUFA’s progress through the Senate. Corpus Callosum has three posts on three New England Journal of Medicine editorials about PDUFA (here, here, and here). (We’ve got Susan Wood’s take on the editorials here; or, check out all our PDUFA posts here.) The Olive Ridley Crawl reports that proposed restrictions on new-drug advertising are meeting fierce resistance. Cervantes at Stayin’ Alive point to another article in NEJM, this one about the antibiotic Ketek, which the FDA approved despite safety concerns. Meanwhile, Mike the Mad Biologist looks at E. coli and the inadequacy of funding for FDA’s food inspection work.
Elsewhere in the blogosphere …
Paul Higgins at Climate Policy puts per-country CO2 emissions in perspective.
Gavin at RealClimate gives us the scoop on ocean cooling (or the lack thereof).
Corie Lok at Nature Network Boston has the latest on the greening of Boston.
David Roberts at Gristmill investigates the money behind a Utah energy summit and finds Astroturf.
Jessica Gottlieb at Global Health Policy suggests a research agenda for a not-so-sexy disease.
Orac at Respectful Insolence blasts New Jersey Governor Jon Corzine for not wearing a seatbelt.
And, if you’re interested in the lengthy and intense blogosphere debate on the subject of framing science, Coturnix at A Blog Around the Clock has collected all of the posts in one place.
What else is worth a read? Leave suggestions in the comments.